1. Arcturus Therapeutics will release Q1 2025 financial results on May 12. 2. A conference call will follow the earnings release for stakeholder engagement.
The earnings release may contain important information but depends on actual results; historically, earnings reports can lead to volatility depending on market expectations.
Earnings reports can significantly influence investor sentiment, especially if unexpected results are announced.
Immediate effects around the earnings call may affect stock price volatility, but long-term impacts depend on business performance.